News
There is an unmet need for safe, effective, long-term therapies for autoimmune disorders. NIH inventors have isolated a population of mammalian cells comprising about 75% or higher B-1a regulatory cells (Bregs) and methods of preparation of such cell populations as a therapeutic for immune-related
The Bayh-Dole Coalition has made all of the key documents in the Bayh-Dole legislation public and virtually accessible through a new online library. Previously, these documents were inaccessible and not housed together. Now, these documents have been compiled and annotated with the intent of
NIH will host a free virtual workshop titled Transforming Discoveries into Products: Maximizing NIH’s Levers to Catalyze Technology Transfer. This workshop will discuss the policies and practices that shape biomedical innovation and promote access to NIH-funded discoveries. It will also cover how
Inventors at the National Institute of Dental and Craniofacial Research (NIDCR) are searching for a collaboration partner for a tissue engineering method for treating cartilage damage. Currently, there are no effective treatment options approved to prevent arthritis progression. This method involves